Premium
Temporal dynamics of myelination in the zebrafish spinal cord
Author(s) -
Buckley Clare E.,
Marguerie Anita,
Alderton Wendy K.,
Franklin Robin J. M.
Publication year - 2010
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.20964
Subject(s) - zebrafish , biology , myelin basic protein , remyelination , olig2 , myelin , spinal cord , oligodendrocyte , neuroscience , green fluorescent protein , microbiology and biotechnology , central nervous system , genetics , gene
Knowledge of the precise timing of myelination is critical to the success of zebrafish‐based in vivo screening strategies for potential remyelination therapies. This study provides a systematic review of the timing of myelination in the zebrafish spinal cord and a critique of techniques by which it may be accurately assessed. The onset of myelination was found to be 3 days postfertilization (d.p.f.); earlier than previously reported. This coincided with the dorsal migration and differentiation of oligodendrocytes and the expression of myelin basic protein (Mbp) transcripts and protein. Our data suggests that immunohistochemistry with zebrafish‐specific anti‐Mbp from 3 d.p.f. is the optimal histological method for myelin visualization, while quantification of myelination is more reliably achieved by quantitative polymerase chain reaction (qPCR) for mbp from 5 d.p.f.. Transgenic fluorescent lines such as olig2 :EGFP can be used to assess oligodendrocyte cell number at 3 d.p.f. and the development of new, more specific lines may enable real time visualization of myelin itself. Quantitative ultrastructural analysis revealed that the myelination of zebrafish axons is regulated according to axonal growth and not absolute axonal size. This study confirms the use of the zebrafish larvae as a versatile and efficient in vivo model of myelination and provides a platform on which future myelination screening studies can be based. © 2010 Wiley‐Liss, Inc.